Abstract:Drug-target affinity (DTA) prediction as an emerging and effective method is widely applied to explore the strength of drug-target interactions in drug development research. By predicting these interactions, researchers can assess the potential efficacy and safety of candidate drugs at an early stage, narrowing down the search space for therapeutic targets and accelerating the discovery and development of new drugs. However, existing DTA prediction models mainly use graphical representations of drug molecules, which lack information on interactions between individual substructures, thus affecting prediction accuracy and model interpretability. Therefore, transformer and diffusion on drug graphs in DTA prediction (TDGraphDTA) are introduced to predict drug-target interactions using multi-scale information interaction and graph optimization. An interactive module is integrated into feature extraction of drug and target features at different granularity levels. A diffusion model-based graph optimization module is proposed to improve the representation of molecular graph structures and enhance the interpretability of graph representations while obtaining optimal feature representations. In addition, TDGraphDTA improves the accuracy and reliability of predictions by capturing relationships and contextual information between molecular substructures. The performance of the proposed TDGraphDTA in DTA prediction was verified on three publicly available benchmark datasets (Davis, Metz, and KIBA). Compared with state-of-the-art baseline models, it achieved better results in terms of consistency index, R-squared, etc. Furthermore, compared with some existing methods, the proposed TDGraphDTA is demonstrated to have better structure capturing capabilities by visualizing the feature capturing capabilities of the model using Grad-AAM toxicity labels in the ToxCast dataset. The corresponding source codes are available at https://github.com/Lamouryz/TDGraph.

HSGCL-DTA: Hybrid-scale Graph Contrastive Learning Based Drug-Target Binding Affinity Prediction

Predicting drug–target binding affinity with cross-scale graph contrastive learning

GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

Supervised graph co-contrastive learning for drug–target interaction prediction

Semi-supervised heterogeneous graph contrastive learning for drug-target interaction prediction

NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Drug-target Binding Affinity Prediction Model Based on Multi-Scale Diffusion and Interactive Learning

Hierarchical graph representation learning for the prediction of drug-target binding affinity

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

Multimodal contrastive representation learning for drug-target binding affinity prediction

Drug–target affinity prediction with extended graph learning-convolutional networks

Drug-target Affinity Prediction Method Based on Multi-Scale Information Interaction and Graph Optimization

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

Drug Target Affinity Prediction Based on Graph Structural Enhancement and Multi-scale Topological Feature Fusion

A Heterogeneous Network-based Contrastive Learning Approach for Predicting Drug-Target Interaction

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction